RFRP-1 inhibitors are a class of chemical compounds designed to target and modulate the activity of RFRP-1 (RFamide-related peptide-1), which is a neuropeptide found in the hypothalamus of mammals. These inhibitors are primarily utilized in research settings to elucidate the physiological roles and regulatory mechanisms associated with the RFRP-1 system. RFRP-1 itself is known for its role in the regulation of reproductive processes and the control of gonadotropin-releasing hormone (GnRH) secretion, which in turn influences the reproductive axis.
RFRP-1 inhibitors is to block or downregulate the activity of RFRP-1 receptors in order to investigate the impact of this modulation on various physiological processes. By doing so, researchers can gain insights into the intricate neural circuits and signaling pathways that underlie reproductive control, circadian rhythms, and other related functions. These inhibitors often work by binding to RFRP-1 receptors, preventing the binding of the endogenous ligand (RFRP-1 itself), and subsequently altering the downstream signaling cascade. Additionally, RFRP-1 inhibitors are instrumental in studying the interplay between the RFRP-1 system and other neuropeptides and hormones involved in reproductive and endocrine regulation. Overall, RFRP-1 inhibitors are invaluable tools for advancing our understanding of neuroendocrinology and the intricate mechanisms that govern reproductive physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cenicriviroc | 497223-25-3 | sc-504755 | 1 mg | $640.00 | ||
Cenicriviroc is a dual CCR2 and CCR5 antagonist that can influence NPVF indirectly by altering the signaling mechanisms associated with these chemokine receptors. | ||||||
AZD 5069 | 878385-84-3 | sc-507447 | 5 mg | $230.00 | ||
AZD-5069 is a CXCR2 antagonist that can have an indirect inhibitory effect on NPVF by targeting CXCR2-related signaling pathways. | ||||||
SB 225002 | 182498-32-4 | sc-202803 sc-202803A | 1 mg 5 mg | $36.00 $102.00 | 2 | |
SB225002 is a CXCR2 selective antagonist that can indirectly inhibit NPVF by affecting the signaling pathways associated with CXCR2. | ||||||
WZ811 | 55778-02-4 | sc-296701 sc-296701A | 1 mg 5 mg | $29.00 $66.00 | ||
WZ811 is a CXCR4 antagonist that can indirectly inhibit the NPVF protein by perturbing the CXCR4-linked signaling pathways. | ||||||